Trial Profile
Losartan Effects on the Extinction of Conditioned Fear in Humans
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2020
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Diabetic nephropathies; Heart failure; Hypertension
- Focus Pharmacodynamics
- 04 Jun 2018 Planned End Date changed from 31 Jul 2018 to 31 Dec 2018.
- 04 Jun 2018 Planned primary completion date changed from 31 Mar 2018 to 31 Oct 2018.
- 15 Jan 2018 New trial record